Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 2Withdrawn 1Unknown 1Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 24Neoplasms 4Multiple Myeloma 2Lymphoma, Non-Hodgkin 2Hodgkin Disease 2Sleep Apnea, Obstructive 1Recurrence 1Prostate Adenocarcinoma 1Premenopausal Breast Cancer 1Polycystic Ovary Syndrome 1Myeloproliferative Disorders 1Metabolic Syndrome 1Lymphoma, Mantle-Cell 1Leukemia, Myeloid, Acute 1Leiomyoma 1Insulin Resistance 1Glucose Intolerance 1Breast Neoplasms 1

Interventions

Metformin 7Clomiphene 4Progesterone 2Pioglitazone 2Medroxyprogesterone Acetate 2Inositol 2Folic Acid 2Flutamide 2Estrogens 2Estradiol 2salicylsalicylic acid 1ganirelix 1Thioctic Acid 1Sugars 1Resistance Training 1Raloxifene Hydrochloride 1Progestins 1Nutrition Assessment 1Methyltestosterone 1Magnesium 1Linseed Oil 1Leuprolide 1LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)- 1Itraconazole 1Gonadotropins 1Flour 1Fenofibrate 1Exercise 1Docosahexaenoic Acids 1Diet Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Polycystic Ovary Syndrome × Leuprolide × Clear all
NCT00203996 2023-03-21

Polycystic Ovary Syndrome (PCOS) and Sleep Apnea

University of Chicago

Phase 4 Terminated
37 enrolled 15 charts

Insulin Resistance, Polycystic Ovary Syndrome, Glucose Intolerance, Sleep Apnea, Obstructive, Metabolic Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡